Gene

Search results

No.	KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related	KEGG GENES	KEGG DRUG	DrugBank	指定難病告示番号
1	Aldosterone synthesis and secretion 💬	3件: CACNA1G, CACNA1H, CACNA1I 💬	D07971 💬	Flunarizine	1件: 149 💬
2	Amyotrophic lateral sclerosis 💬	1件: SIGMAR1 💬	D07945 💬	Fenfluramine	4件: 140, 144, 145, 149 💬
3	Calcium signaling pathway 💬	3件: CACNA1G, CACNA1H, CACNA1I 💬	D07971 💬	Flunarizine	1件: 149 💬
4	Calcium signaling pathway 💬	2件: HTR2A, HTR2C 💬	D07945 💬	Fenfluramine	4件: 140, 144, 145, 149 💬
5	cAMP signaling pathway 💬	2件: GABBR1, GABBR2 💬	D00241 💬	Baclofen	8件: 2 , 10, 13, 18, 65, 70, 149, 206 💬
6	cAMP signaling pathway 💬	1件: HTR1D 💬	D07945 💬	Fenfluramine	4件: 140, 144, 145, 149 💬
7	Circadian entrainment 💬	3件: CACNA1G, CACNA1H, CACNA1I 💬	D07971 💬	Flunarizine	1件: 149 💬
8	Cortisol synthesis and secretion 💬	3件: CACNA1G, CACNA1H, CACNA1I 💬	D07971 💬	Flunarizine	1件: 149 💬
9	Cushing syndrome 💬	3件: CACNA1G, CACNA1H, CACNA1I 💬	D07971 💬	Flunarizine	1件: 149 💬
10	ECM-receptor interaction 💬	1件: SV2A 💬	D08879 💬	Brivaracetam	2件: 149, 309 💬
11	ECM-receptor interaction 💬	3件: SV2A, SV2B, SV2C 💬	D11842 💬	Padsevonil	1件: 149 💬
12	Estrogen signaling pathway 💬	2件: GABBR1, GABBR2 💬	D00241 💬	Baclofen	8件: 2 , 10, 13, 18, 65, 70, 149, 206 💬
13	GABAergic synapse 💬	2件: GABBR1, GABBR2 💬	D00241 💬	Baclofen	8件: 2 , 10, 13, 18, 65, 70, 149, 206 💬
14	Gap junction 💬	2件: HTR2A, HTR2C 💬	D07945 💬	Fenfluramine	4件: 140, 144, 145, 149 💬
15	GnRH secretion 💬	3件: CACNA1G, CACNA1H, CACNA1I 💬	D07971 💬	Flunarizine	1件: 149 💬
16	GnRH secretion 💬	2件: GABBR1, GABBR2 💬	D00241 💬	Baclofen	8件: 2 , 10, 13, 18, 65, 70, 149, 206 💬
17	Inflammatory mediator regulation of TRP channels 💬	2件: HTR2A, HTR2C 💬	D07945 💬	Fenfluramine	4件: 140, 144, 145, 149 💬
18	Insulin secretion 💬	1件: SNAP25 💬	D00783 💬	Botulinum toxin type A	14件: 2 , 5 , 6 , 7 , 13, 15, 17, 36, 47, 51, 70, 113, 149, 226 💬
19	MAPK signaling pathway 💬	3件: CACNA1G, CACNA1H, CACNA1I 💬	D07971 💬	Flunarizine	1件: 149 💬
20	Morphine addiction 💬	2件: GABBR1, GABBR2 💬	D00241 💬	Baclofen	8件: 2 , 10, 13, 18, 65, 70, 149, 206 💬
21	Neuroactive ligand-receptor interaction 💬	2件: GABBR1, GABBR2 💬	D00241 💬	Baclofen	8件: 2 , 10, 13, 18, 65, 70, 149, 206 💬
22	Neuroactive ligand-receptor interaction 💬	3件: HTR1D, HTR2A, HTR2C 💬	D07945 💬	Fenfluramine	4件: 140, 144, 145, 149 💬
23	Pathways of neurodegeneration - multiple diseases 💬	1件: SIGMAR1 💬	D07945 💬	Fenfluramine	4件: 140, 144, 145, 149 💬
24	Serotonergic synapse 💬	4件: HTR1D, HTR2A, HTR2C, SLC6A4 💬	D07945 💬	Fenfluramine	4件: 140, 144, 145, 149 💬
25	Synaptic vesicle cycle 💬	1件: SLC6A4 💬	D07945 💬	Fenfluramine	4件: 140, 144, 145, 149 💬
26	Synaptic vesicle cycle 💬	1件: SNAP25 💬	D00783 💬	Botulinum toxin type A	14件: 2 , 5 , 6 , 7 , 13, 15, 17, 36, 47, 51, 70, 113, 149, 226 💬
27	Taste transduction 💬	2件: GABBR1, GABBR2 💬	D00241 💬	Baclofen	8件: 2 , 10, 13, 18, 65, 70, 149, 206 💬
28	Taste transduction 💬	1件: HTR1D 💬	D07945 💬	Fenfluramine	4件: 140, 144, 145, 149 💬
29	Taste transduction 💬	2件: SCN3A, SCN9A 💬	D07299 💬	Lacosamide	4件: 2 , 46, 149, 298 💬
30	Type II diabetes mellitus 💬	1件: CACNA1G 💬	D07971 💬	Flunarizine	1件: 149 💬

先頭へ